Market Place
Sourcing Support
Cumberland Pharma to Report Q3 2025 Financials & Company Update
29 Oct 2025 //
PR NEWSWIRE
Cumberland Adds FDA-Approved Product to Commercial Portfolio
20 Oct 2025 //
PR NEWSWIRE
Tabuk Introduces FDA-Approved Vibativ Antibiotic In Saudi Arabia
29 Sep 2025 //
PR NEWSWIRE
Vizient awards Cumberland Pharmaceuticals contract for Vibativ
04 Aug 2025 //
PR NEWSWIRE
New Publication Reveals Real-World Usage of Vibativ® In Patients
26 May 2020 //
PR NEWSWIRE
Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
11 May 2020 //
PHARMIWEB
Cumberland Pharma Announces Initiative To Expand Availability Of VIBATIV®
23 Mar 2020 //
PR NEWSWIRE
New Study Reveals Real-World Usage of Vibativ In a Variety Of Infections
25 Nov 2019 //
PR NEWSWIRE
Theravance to present new data from TOUR study of Vibativ
19 Jan 2017 //
PHARMABIZ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.